Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily V Mesev

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nature Microbiology|April 3, 2019
Decoding type I and III interferon signalling during viral infectionEmily V Mesev, Robert A LeDesma, Alexander Ploss
Molecular Pharmacology|January 26, 2017
Ceramide 1-Phosphate Increases P-Glycoprotein Transport Activity at the Blood-Brain Barrier via Prostaglandin E2 SignalingEmily V Mesev, David S Miller, Ronald E Cannon
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 19, 2023
Synthetic Heterodimers of Type III Interferon Receptors Require TYK2 for STAT ActivationEmily V Mesev, Emma G Guare, Alexander Ploss, et al.
Journal of Virology|September 18, 2024
Engineered chimeric receptors for dissecting interferon signalingAaron E Lin, Emily V Mesev, Jared E Toettcher, et al.
Neuroscience Letters|December 25, 2016
Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal modelGary N Y Chan, Rebecca A Evans, David B Banks, et al.
Science Signaling|October 10, 2023
Membrane-proximal motifs encode differences in signaling strength between type I and III interferon receptorsEmily V Mesev, Aaron E Lin, Emma G Guare, et al.
Elife|May 22, 2023
pYtags enable spatiotemporal measurements of receptor tyrosine kinase signaling in living cellsPayam E Farahani, Xiaoyu Yang, Emily V Mesev, et al.
The Journal of Clinical Investigation|January 18, 2024
Sterol biosynthesis regulates TLR signaling and the innate immune response in a Smith-Lemli-Opitz syndrome modelKristin Gabor, Emily V Mesev, Jennifer Madenspacher, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nature Microbiology|April 3, 2019
Decoding type I and III interferon signalling during viral infectionEmily V Mesev, Robert A LeDesma, Alexander Ploss
Molecular Pharmacology|January 26, 2017
Ceramide 1-Phosphate Increases P-Glycoprotein Transport Activity at the Blood-Brain Barrier via Prostaglandin E2 SignalingEmily V Mesev, David S Miller, Ronald E Cannon
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 19, 2023
Synthetic Heterodimers of Type III Interferon Receptors Require TYK2 for STAT ActivationEmily V Mesev, Emma G Guare, Alexander Ploss, et al.
Journal of Virology|September 18, 2024
Engineered chimeric receptors for dissecting interferon signalingAaron E Lin, Emily V Mesev, Jared E Toettcher, et al.
Neuroscience Letters|December 25, 2016
Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal modelGary N Y Chan, Rebecca A Evans, David B Banks, et al.
Science Signaling|October 10, 2023
Membrane-proximal motifs encode differences in signaling strength between type I and III interferon receptorsEmily V Mesev, Aaron E Lin, Emma G Guare, et al.
Elife|May 22, 2023
pYtags enable spatiotemporal measurements of receptor tyrosine kinase signaling in living cellsPayam E Farahani, Xiaoyu Yang, Emily V Mesev, et al.
The Journal of Clinical Investigation|January 18, 2024
Sterol biosynthesis regulates TLR signaling and the innate immune response in a Smith-Lemli-Opitz syndrome modelKristin Gabor, Emily V Mesev, Jennifer Madenspacher, et al.
Pageof 1